Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$8.9 million as the latest value for Q4 2018.

  • Quarterly Net Income towards Common Stockholders fell 282.49% to -$8.9 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$16.7 million through Dec 2018, down 16.16% year-over-year, with the annual reading at -$53.2 million for FY2025, 0.09% changed from the prior year.
  • Net Income towards Common Stockholders hit -$8.9 million in Q4 2018 for Armata Pharmaceuticals, down from -$1.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $8.9 million in Q2 2015 to a low of -$14.8 million in Q1 2015.
  • Historically, Net Income towards Common Stockholders has averaged -$4.4 million across 5 years, with a median of -$3.4 million in 2016.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 606.44% in 2014 and later surged 338.94% in 2015.
  • Year by year, Net Income towards Common Stockholders stood at -$994000.0 in 2014, then crashed by 219.92% to -$3.2 million in 2015, then tumbled by 198.74% to -$9.5 million in 2016, then skyrocketed by 75.47% to -$2.3 million in 2017, then crashed by 282.49% to -$8.9 million in 2018.
  • Business Quant data shows Net Income towards Common Stockholders for ARMP at -$8.9 million in Q4 2018, -$1.6 million in Q3 2018, and -$3.0 million in Q2 2018.